Search Within

Sujata Patil

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (13)
Groups
  1. Biostatistics Service (30)
  2. Epidemiology and Biostatistics (30)
  3. Molecular Imaging and Therapy Service (30)
  4. Radiology, Department of (29)
  5. Department of Medicine (24)
  6. Solid Tumor Oncology Division (24)

More Groups

People
  1. Clifford Hudis (12)
  2. Maxine Jochelson (12)
  3. Komal Jhaveri (10)
  4. Steven Larson (9)
  5. Shanu Modi (8)
  6. Heather Mcarthur (7)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (6)
  6. 2017 (3)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer Research (3)
  3. Annals of Surgical Oncology (2)
  4. BMC Urology (1)
  5. Breast Cancer Research and Treatment (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (4)
  3. Springer (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
    Journal Article

    Comen, E.; Budhu, S.; Elhanati, Y.; Page, D.; Rasalan-Ho, T.; Ritter, E.; Wong, P.; Plitas, G.; Patil, S.; Brogi, E.; more...
    iScience (2024)

    Fulltext@MSK | Save
  • Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade
    Journal Article

    Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging
    Journal Article

    Morikawa, A.; Grkovski, M.; Patil, S.; Jhaveri, K. L.; Tang, K.; Humm, J. L.; Holodny, A.; Beal, K.; Schòˆder, H.; Seidman, A. D.
    Breast Cancer Research and Treatment (2021)

    Fulltext@MSK | Save
  • Measuring tumor epichaperome expression using [(124)I] PU-H71 positron emission tomography as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2-negative metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; dos Anjos, C. H.; Taldone, T.; Wang, R.; Comen, E.; Fornier, M.; Bromberg, J. F.; Ma, W.; Patil, S.; Rodina, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
    Journal Article

    Ged, Y.; Gupta, R.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    BMC Urology (2020)

    Fulltext@MSK | Save
  • The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
    Journal Article

    Inda, M. C.; Joshi, S.; Wang, T.; Bolaender, A.; Gandu, S.; Koren, J. 3rd; Che, A. Y.; Taldone, T.; Yan, P.; Sun, W.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative FLT-PET brain imaging study in patients receiving WBRT +/- sorafenib
    Meeting Abstract

    Morikawa, A.; Grkovski, M.; Patil, S.; Jhaveri, K.; Tang, K.; Humm, J.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A.
    Neuro-Oncology Advances (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)
    Meeting Abstract

    Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save